Geode Capital Management, LLC Ligand Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 405,775 shares of LGND stock, worth $46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

405,775

Previous 380,970 6.51%

Holding current value

$46 Million

Previous $27.8 Million 22.77%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$68.53 - $87.91 $1.7 Million - $2.18 Million	24,805 Added 6.51%	405,775 $34.2 Million
Q1 2024 May 13, 2024	BUY	$68.64 - $89.2 $697,039 - $905,826	10,155 Added 2.74%	380,970 $27.8 Million
Q4 2023 Feb 13, 2024	BUY	$49.57 - $72.63 $901,876 - $1.32 Million	18,194 Added 5.16%	370,815 $26.5 Million
Q3 2023 Nov 13, 2023	BUY	$58.86 - $72.67 $647,930 - $799,951	11,008 Added 3.22%	352,621 $21.1 Million
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $1.73 Million - $1.97 Million	24,814 Added 7.83%	341,613 $24.6 Million
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $1.06 Million - $1.24 Million	16,129 Added 5.36%	316,799 $23.3 Million
Q4 2022 Feb 13, 2023	BUY	$61.72 - $96.74 $651,763 - $1.02 Million	10,560 Added 3.64%	300,670 $20.1 Million
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $6 - $66,149	-615 Reduced 0.21%	290,110 $25 Million
Q2 2022 Aug 12, 2022	SELL	$74.52 - $117.06 $735,661 - $1.16 Million	-9,872 Reduced 3.28%	290,725 $25.9 Million
Q1 2022 May 13, 2022	BUY	$94.99 - $151.56 $1.51 Million - $2.41 Million	15,934 Added 5.6%	300,597 $33.8 Million
Q4 2021 Feb 11, 2022	BUY	$127.69 - $165.85 $1.1 Million - $1.43 Million	8,648 Added 3.13%	284,663 $44 Million
Q3 2021 Nov 12, 2021	SELL	$102.33 - $144.73 $158,099 - $223,607	-1,545 Reduced 0.56%	276,015 $38.5 Million
Q2 2021 Aug 13, 2021	BUY	$113.03 - $155.64 $1.66 Million - $2.29 Million	14,684 Added 5.59%	277,560 $36.4 Million
Q1 2021 May 12, 2021	BUY	$99.52 - $215.83 $2.89 Million - $6.27 Million	29,069 Added 12.43%	262,876 $40.1 Million
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $158,764 - $209,024	1,971 Added 0.85%	233,807 $23.3 Million
Q3 2020 Nov 13, 2020	SELL	$89.56 - $126.72 $810,249 - $1.15 Million	-9,047 Reduced 3.76%	231,836 $22.1 Million
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $1.29 Million - $2.34 Million	-18,940 Reduced 7.29%	240,883 $26.9 Million
Q1 2020 May 14, 2020	BUY	$63.37 - $107.88 $628,440 - $1.07 Million	9,917 Added 3.97%	259,823 $18.9 Million
Q4 2019 Feb 13, 2020	SELL	$96.94 - $113.59 $735,677 - $862,034	-7,589 Reduced 2.95%	249,906 $26.1 Million
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $411,585 - $573,403	-4,772 Reduced 1.82%	257,495 $25.6 Million
Q2 2019 Aug 14, 2019	BUY	$107.38 - $129.34 $270,490 - $325,807	2,519 Added 0.97%	262,267 $29.9 Million
Q1 2019 May 14, 2019	BUY	$105.93 - $142.47 $1.2 Million - $1.61 Million	11,288 Added 4.54%	259,748 $32.7 Million
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $2.67 Million - $5.65 Million	20,769 Added 9.12%	248,460 $33.7 Million
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $1.49 Million - $1.94 Million	7,054 Added 3.2%	227,691 $62.5 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $3.42 Million - $4.72 Million	22,710 Added 11.47%	220,637 $45.7 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $1.07 Million - $1.41 Million	7,741 Added 4.07%	197,927 $32.7 Million
Q4 2017 Feb 13, 2018	BUY	$128.36 - $147.04 $1.28 Million - $1.47 Million	10,006 Added 5.55%	190,186 $26 Million
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $232,389 - $265,120	1,922 Added 1.08%	180,180 $24.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	178,258	178,258 $21.6 Million

Others Institutions Holding LGND

# of Institutions

249

Shares Held

17.7M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Ligand Pharmaceuticals Inc Transaction History